Free Trial

American Oncology Network (AONC) Insider Trading & Ownership

American Oncology Network logo
$3.30
+0.19 (+6.11%)
(As of 11/1/2024 ET)

American Oncology Network (NASDAQ:AONC) Insider Buying and Selling Activity

Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$20,735.80
Number Of
Insiders Selling
(Last 12 Months)
0
Get AONC Insider Trade Alerts

Want to know when executives and insiders are buying or selling American Oncology Network stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AONC Insider Buying and Selling by Quarter

American Oncology Network Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/24/2024Stephen DiversInsiderBuy5,000$2.15$10,750.00  
5/21/2024Todd SchonherzCEOBuy5,340$1.87$9,985.80  
(Data available from 1/1/2013 forward)

AONC Insider Trading Activity - Frequently Asked Questions

The list of insiders at American Oncology Network includes Saba Capital Management, L.P., Stephen Divers, and Todd Schonherz. Learn more on insiders at AONC.

The following insiders have purchased AONC shares in the last 24 months: Stephen Divers ($10,750.00), and Todd Schonherz ($9,985.80).

Insiders have purchased a total of 10,340 AONC shares in the last 24 months for a total of $20,735.80 bought.

The following insider sold AONC shares in the last 24 months: Saba Capital Management, L.P. ($2,157,876.00).

Insiders have sold a total of 205,512 American Oncology Network shares in the last 24 months for a total of $2,157,876.00 sold.

American Oncology Network Key Executives

  • Mr. David H. Gould CPA (Age 54)
    Chief Financial Officer
    Compensation: $1.73M
  • Mr. Mark Moch
    Chief Information Officer
  • Ms. Kristin Matisziw
    Chief Compliance & Risk Officer
  • Ms. Erica Mallon (Age 36)
    General Counsel
  • Ms. Caroline Hewitt
    Vice President of Marketing
  • Mr. James Gilmore Pharm.D.
    Chief Pharmacy & Clinical Services Officer
  • Ms. Shelly Glenn
    Chief Growth & Relationship Officer
  • Ms. Karen Pilley
    Chief Revenue Cycle Officer
  • Mr. Anthony V. Belott
    Chief Development Officer
  • Mr. Steven Swart
    Executive Vice President of Practice Operations


This page (NASDAQ:AONC) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners